A new non-hormonal platelet rich plasma injection may help women with breast cancer ease menopause symptoms like UTIs, ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...
October is Breast Cancer Awareness Month, and cancer awareness starts with general breast awareness. Dr. Julie Nangia, ...
The melanoma market is expected to witness sustained growth driven by continuous therapeutic innovation and wider patient access. Advances in immunotherapies and targeted treatments, along with ...
Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...
Q: I want to do everything I can to stay brain sharp my whole life, especially now that I know I have a genetic ...
HOUSTON, TX, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, ...
Two artificial intelligence (AI) programs -- including ChatGPT -- have passed the U.S. Medical Licensing Examination (USMLE), according to two recent papers. The papers highlighted different ...
A specially developed cannabis extract relieves chronic lower back pain, according to a clinical trial published Wednesday that experts are calling the first high-quality evidence that something in ...
The pass rate for the first level of the chartered financial analyst exam fell to 43% for humans even as artificial-intelligence models have advanced to the point they can ace the final and hardest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback